RXII

RXI Pharmaceuticals Corporation (RXII)

Rxi Pharmaceuticals Corp. (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RXII

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2019/02/15	21 : 15	PR Newswire (US)	Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/12/10	23 : 35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/11/26	23 : 30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/11/20	07 : 52	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/11/14	21 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/11/14	21 : 10	PR Newswire (US)	RXi Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/11/14	21 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/11/14	07 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/11/13	23 : 26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/11/07	21 : 05	PR Newswire (US)	RXi Pharmaceuticals to Present New Data Demonstrating the Ability of sd-rxRNA to Enhance NK Cell Activity for Adoptive Cell T...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/11/06	21 : 05	PR Newswire (US)	RXi Pharmaceuticals to Webcast Third Quarter 2018 Financial Results on Wednesday, November 14, 2018	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/29	22 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/15	22 : 26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/11	03 : 00	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/06	06 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/04	05 : 31	PR Newswire (US)	RXi Pharmaceuticals Announces Closing Of $15 Million Underwritten Public Offering	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/03	06 : 32	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/03	06 : 30	Edgar (US Regulatory)	Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/02	01 : 42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/01	19 : 39	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-1mef)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/01	19 : 36	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/10/01	19 : 10	PR Newswire (US)	RXi Pharmaceuticals Announces Pricing Of $15 Million Upsized Underwritten Public Offering	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/09/28	19 : 14	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/09/26	21 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/09/26	21 : 00	PR Newswire (US)	RXi Pharmaceuticals to Present New Data from its Immuno-Oncology Program Using sd-rxRNA Therapeutic Compounds Targeting Intra...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/09/15	06 : 48	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/09/15	06 : 48	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/09/04	20 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/09/01	06 : 32	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
2018/08/28	22 : 15	PR Newswire (US)	RXi Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)